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Abstract
Introduction: Chronic exposure to high levels of ozone induces emphysema and chronic inflammation in mice. We
determined the recovery from ozone-induced injury and whether an antioxidant, N-acetylcysteine (NAC), could
prevent or reverse the lung damage.
Methods: Mice were exposed to ozone (2.5 ppm, 3 hours/12 exposures, over 6 weeks) and studied 24 hours (24h)
or 6 weeks (6W) later. Nac (100 mg/kg, intraperitoneally) was administered either before each exposure (preventive)
or after completion of exposure (therapeutic) for 6 weeks.
Results: After ozone exposure, there was an increase in functional residual capacity, total lung volume, and lung
compliance, and a reduction in the ratio of forced expiratory volume at 25 and 50 milliseconds to forced vital capacity
(FEV25/FVC, FEV50/FVC). Mean linear intercept (Lm) and airway hyperresponsiveness (AHR) to acetylcholine
increased, and remained unchanged at 6W after cessation of exposure. Preventive NAC reduced the number of BAL
macrophages and airway smooth muscle (ASM) mass. Therapeutic NAC reversed AHR, and reduced ASM mass
and apoptotic cells.
Conclusion: Emphysema and lung function changes were irreversible up to 6W after cessation of ozone exposure,
and were not reversed by NAC. The beneficial effects of therapeutic NAC may be restricted to the ASM.
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Introduction
Chronic obstructive pulmonary disease (COPD) is a major
cause of global morbidity and mortality, and is characterised by
inflammation and fibrosis of the small airways and parenchymal
destruction (emphysema), which ultimately contribute to
irreversible airflow obstruction [1]. Cigarette smoking is the
main etiological cause of COPD, but other factors including
indoor and outdoor air pollution have also been associated with
the development of COPD[2]. Oxidative stress, due to the
increased exogenous oxidants from inhalation of cigarette
smoke and environmental pollutants or endogenous oxidants
generated from inflammatory cells, plays an important
pathogenic role in COPD [3,4]. The development of a chronic
exposure model to ozone in mice that results in chronic lung
inflammation and emphysema also provides direct support for
an important role for oxidative stress in COPD[5]. Oxidative
stress mediates the recruitment of inflammatory cells, activates
kinases such as mitogen-activated protein kinase and
phospho-inositol-3-kinase and transcription factors such as NF-
κB and AP-1 to up-regulate pro-inflammatory gene expression,
that leads to a chronic inflammatory response [4,6] and the
development of emphysema through the initiation of
extracellular matrix proteolysis and endothelial and epithelial
cell apoptosis [6,7]. In addition, oxidative stress on the lungs
may induce airway smooth muscle hyperplasia and
dysfunction, and contribute to ensuing bronchial
hyperresponsiveness (BHR) (1,4,5).
Currently, there are no effective treatments to reverse the
process of COPD. N-acetylcysteine (NAC), an acetyl derivative
of cysteine, which increases intracellular reduced glutathione
(GSH) in the lungs and neutralizes oxidant species [8] has
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been used in the treatment of COPD as a mucolytic agent.
NAC has been reported to reduce oxidative markers in COPD
patients, but yielded mixed effects regarding any improvements
in lung function [8,9]. In experimental studies, NAC attenuated
elastase-induced emphysema in rats [10], but did not affect
emphysema induced by cigarette smoke in mice [11]. The
effect of NAC in a direct oxidant-induced model such as the
chronic ozone exposure model is not known.
In the present study, we examined the preventive and
therapeutic effects of NAC on inflammation, pulmonary
function, airway responsiveness, emphysema, and
inflammatory gene expression in chronic ozone-induced murine
model of COPD. In so doing, we also determined whether the
ozone-induced lung changes could reverse spontaneously with
time.
Materials and Methods
The experiments were performed within the legal framework
of the United Kingdom under a Project License granted by the
Home Office of Her Majesty's government. The researchers
hold Personal Licenses provided by the Home Office of Her
Majesty's government to perform the specific experiments
described here. 
A complete description is provided in the Online
supplement in File S1
Ozone exposure and lung function.  C57/BL6 mice
(Harlan, UK) were exposed to ozone (3 hours; 2.5 parts per
million) [5] (Figure S1). NAC (100mg/Kg, i.p) or PBS was
administered one hour before ozone exposure twice a week for
6 weeks or after cessation of ozone exposure twice a week for
6 weeks.
At either the end of week 6 or 12, mice were anesthetized,
tracheostomized and placed in a body plethysmograph
(eSpira™ Forced Manoeuvers System, EMMS, Hants, UK).
Functional residual capacity (FRC) was determined by Boyle’s
law, and chord compliance (Cchord) was measured from the
quasi-static pressure-volume manoeuvre. Inspiratory capacity
(IC), total lung capacity (TLC), forced vital capacity (FVC) and
the forced expiratory volume in first 25 and 50 milliseconds of
exhalation (FEV25, FEV50) were recorded during fast-flow
volume manoeuvre.
Airway responsiveness to acetylcholine (ACh) was measured
in ventilated mice and transpulmonary pressure was assessed
via an esophageal catheter. Pulmonary resistance (RL) was
recorded in response to increasing concentrations of nebulised
ACh. The concentration of ACh required to increase RL by
150% from baseline was calculated (PC150).
Following terminal anaesthesia, bronchoalveolar lavage
(BAL) fluid was obtained. Total cell and differential cell counts
from cytospins stained by Diff-Quick method were measured.
BAL malondialdehyde (MDA) was measured using a HPLC
system with fluorescent detection (Waters, Milford, MA, USA).
Serum 8-hydroxy-deoxyguanosine (8-OHdG), a major product
of DNA oxidation, was quantified by solid phase extraction
coupled with LC-MS/MS.
Lung morphometric analysis
Five µm sections of paraffin-embedded left lung were stained
with haematoxylin and eosin (H&E) or Masson’s trichrome. We
examined 3-4 medium-sized bronchi within the range of 60 to
125 µm diameter. The severity of inflammatory response in
peribronchial and perivascular in H&E sections was scored on
a 0–3 scale: 0= no inflammatory response; 1=mild inflammation
with foci of inflammatory cells in bronchial or vascular wall and
in alveolar septa; 2=moderate inflammation with patchy
inflammation or localized inflammation in walls of bronchi or
blood vessels and alveolar septa, and less than one-third of
lung cross-sectional area is involved; and 3=severe
inflammation with diffuse inflammatory cells in walls of bronchi
or blood vessels and alveoli septa; between one-third and two-
thirds of the lung area is involved.
The mean linear intercept (Lm), a measure of interalveolar
septal wall distance, was determined and calculated by dividing
the length of the line by the number of alveolar wall and grid
line interception counted. 3-4 medium sized bronchial walls in
Masson’s trichrome-stained sections were point-counted to
assess morphological changes of airway epithelium, collagen
deposition and airway smooth muscle (ASM) mass.
Lung sections were incubated with peroxidase blocking
solution (Dako, Cambridge, UK) and rabbit anti-apoptosis
protease activating factor-1 (APA-1) primary antibody,
polyclonal goat anti-rabbit horseradish peroxidase (HRP)-
conjugated secondary antibody followed by diaminobenzidine
(DAB) liquid. The immunostaining intensity for APA-1 in the
airway epithelium was scored on 0-3 scale. The number of
APA-1 positive cell per field was also counted.
Reverse transcription and real-time PCR
Total RNA was extracted from lungs using an RNeasy Mini
Kit (Qiagen, West Sussex, UK) and then was reverse-
transcribed to cDNA. Real-time PCR analyses were performed
to determine mRNA levels of IL-1β, Caspse-3, TGF-β, MMP-9,
SOD-2 and HO-1 using Rotor-Gene 3000 (Corbett Research,
Sydney, Australia) and QuantiTect SYBR Green PCR Master
Mix Reagent (Qiagen). Relative abundance of gene expression
was normalized to 18S rRNA expression.
Data analysis
Data are presented as mean ± S.E.M. Two-way analysis of
variance was performed for comparisons of %change in RL
between individual groups within Groups 1, 2 and 3 and
Groups 4, 5 and 6. One-way analysis of variance with LSD
post-test (equal variance) or Dunnett’s T3 post-test (unequal
variance) was performed for comparison between multiple
groups within Groups 1, 2 and 3 and Groups 4, 5 and 6.
Unpaired t-test or Mann-Whitney test was carried out for
comparison between ozone group (Group 2) and ozone
recovery group (Group 5). A p value of <0.05 was considered
significant.
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Results
Pulmonary function measurements
There were significant increases in lung volume parameters
(IC, FRC and TLC) and compliance (Cchord) and decreases in
airflow during expiration (FEV25/FVC, FEV50/FVC) in PBS-
pretreated ozone-exposed mice compared to air-exposed
group (Figure 1). Six weeks after cessation of exposure, the
increase in IC, TLC, Cchord but not in FRC remained elevated
and the decrease in FEV25/FVC and FEV50/FVC also were
unchanged. Preventive and therapeutic NAC treatment did not
have beneficial effect on any of these parameters.
Figure 1.  Lung mechanics.  Individual and mean values of inspiratory capacity (IC)(Panel A), functional residual capacity (FRC)
(Panel B), total lung capacity (TLC) (Panel C), chord compliance (Cchord) (Panel D), and percentage of forced expiratory volume
(FEV) in first 25 and 50 ms of fast expiration (FEV25 and FEV50) of forced vital capacity (FVC)(Panels E,F). *compared with air
control, *P<0.05, **P<0.01, ***P<0.001.
doi: 10.1371/journal.pone.0080782.g001
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Airway responsiveness
PBS-pretreated ozone-exposed mice demonstrated a
significant increase in airway responsiveness to ACh compared
to air control mice (Figure 2C). Preventive NAC treatment did
not alter the airway hyperresponsiveness seen in ozone-
exposed mice (Figure 2A). After 6 weeks of recovery, ozone-
exposed PBS-treated mice still demonstrated an increased
airway responsiveness to ACh (P<0.001). Therapeutic
intervention with NAC reversed the airway responsiveness of
ozone-exposed mice compared to ozone-exposed PBS-treated
mice (P<0.001; Figure 2B).
Figure 2.  Airway hyperresponsiveness.  Mean percentage increase in lung resistance (RL) to increasing concentrations of
acetylcholine is shown in Panel A.. Three groups of mice were studied: air-exposed mice (n=8), PBS-pretreated ozone-exposed
mice (n=7), NAC-pretreated ozone-exposed mice (n=8). *P<0.05, **P<0.01, ***P<0.001 compared with air control. Data is expressed
as means ±S.E.M. ○: Air exposure 6w,●: ozone-exposure 6w,▲:ozone-exposure and NAC-treatment 6w. Panel B. Mean
percentage increase in lung resistance to increasing concentrations of acetylcholine, *P<0.05, **P<0.01, ***P<0.001 compared with air
control; ≠P<0.05, ≠≠P<0.01, ≠≠≠P<0.001 compared with ozone-exposed NAC treated group. Data is expressed as means ±S.E.M.
□:Air exposure 12w, ■: ozone-exposure 6w and then PBS-treatment 6w,▼: ozone-exposure 6w and then NAC-treatment 6w. Panel
C. Individual and mean –log PC150 of the six experimental groups. *P<0.05, **P<0.01.
doi: 10.1371/journal.pone.0080782.g002
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BAL cells
PBS-pretreated ozone-exposed mice demonstrated an
increase in total cell counts in BAL fluid (P<0.01), as reflected
by increased macrophages (P<0.05), neutrophils (P<0.001)
and eosinophils (P<0.001) compared to air-exposed mice
(Figure 3A-E). After 6 weeks cessation of ozone exposure,
there was a decrease in total cell counts including
macrophage, neutrophil and eosinophil in BAL fluid. Preventive
NAC treatment decreased macrophage numbers (P<0.01) and
increased lymphocyte numbers (p<0.05) compared to PBS-
pretreated ozone-exposed mice; therapeutic treatment with
NAC in ozone-exposed mice did not affect total or constituent
cell counts..
Lung inflammation scores
Ozone exposure in PBS-pretreated mice caused an increase
in inflammation scores with peribronchial and perivascular
inflammatory cell infiltrates in lung sections compared to air-
exposed mice (P<0.001, Figure 3F). This inflammatory
response persisted up to 6 weeks after cessation of exposure
to ozone. Preventive treatment with NAC did not lead to a
reduction in lung inflammation scores. Similar findings were
observed with therapeutic NAC.
Figure 3.  Bronchoalveolar lavage cells.  Individual and mean numbers of total cells (TOTAL) (Panel A), macrophages (MAC)
(Panel B), neutrophils (NEU) (Panel C), lymphocytes (LYM) (Panel D), and eosinophils (EOS) (Panel E) in bronchoalveolar lavage
(BAL) fluid for the 6 experimental groups. Panel F. Individual and mean inflammation scores in the airways and lungs. *P<0.05,
**P<0.01, *** P<0.001.
doi: 10.1371/journal.pone.0080782.g003
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BAL MDA levels
Ozone exposure did not lead to an increase in MDA
concentration at 6 weeks, but after 6 weeks of cessation levels
increased significant, indicating a delayed oxidant response
(Figure 4A). Preventive NAC did not affect MDA
concentrations. Therapeutic NAC did not decrease the raised
MDA levels observed after 6 weeks cessation of exposure.
Plasma 8-hydroxy-deguanosine (8OH-dG)
Ozone exposure of PBS-pretreated mice did not increase the
levels of 8-OHdG compared to air-exposed mice (Figure 4B).
Stopping ozone exposure for 6 weeks decreased the
concentration of 8-OHdG in ozone-exposed PBS-treated mice
(P<0.01) and air control mice(P<0.01). Preventive treatment
with NAC reduced the levels of 8-OHdG (P<0.01), while
therapeutic NAC intervention had no effect.
Mean linear intercept, Lm
Figure 5 A-F shows alveolar enlargement at 6 weeks of
ozone exposure, that persisted in mice after 6 weeks of
cessation of exposure. This was reflected in an increase in Lm
after 6 weeks of exposure (P<0.01) and also after 6 weeks of
cessation of exposure (P<0.01; Figure 5G). Neither preventive
nor therapeutic NAC inhibited the ozone-induced increase in
Lm.
Bronchial wall changes
Ozone exposure induced an increase in the proportion of
ASM (P<0.05, Figure 6B), associated with decreased
proportion of collagen (P<0.05, Figure 6C) in PBS-pretreated
mice exposed to ozone. There was recovery of the increase in
ASM cells after stopping exposure for 6 weeks (P<0.01). Both
preventive and therapeutic treatments with NAC significantly
reduced the proportion of ASM in the bronchial wall compared
to PBS-pretreated ozone-exposed mice (P<0.05 and <0.001,
respectively). However, NAC did not have an effect on the
ozone-induced reduction in collagen. Interestingly, therapeutic
NAC increased the epithelial area following ozone exposure
(Figure 6A).
APA-1
Ozone-exposed mice showed increases in APA-1 expression
in the airway epithelium (P<0.001) and APA-1-positive cells
(P<0.05, Figure 7), which persisted at 6 weeks after cessation
of exposure. Preventive NAC treatment did not reduce the
increased expression intensity or positive cell number of APA-1
induced by ozone. Therapeutic NAC treatment reversed the
increase of APA-1 in the airway epithelium and parenchyma
compared to ozone-exposed PBS-treated mice (P<0.05 and
P<0.001, respectively).
Lung gene expression
Ozone exposure in PBS-pretreated mice evoked an
increased mRNA expression of IL-1β, caspase-3, MMP-9,
TGF-β and SOD2 in the lung tissue (Figure 4 B-G). Apart from
caspase-3 expression which fell, there was no change in the
expression of IL-1β, MMP-9, TGF-β, SOD2 and HO-1 after 6
weeks of cessation of exposure. Both preventive and
therapeutic NAC treatment did not affect the mRNA levels of
IL-1β, caspase-3, MMP-9, TGF-β, SOD2 and HO-1 in ozone-
exposed mice compared to PBS-pretreated ozone-exposed
mice
Discussion
We demonstrated that lung inflammation, emphysema,
abnormal lung function and AHR were induced by 6 weeks of
ozone exposure and that these persisted up to 6 weeks after
cessation of exposure. The increased numbers of neutrophils,
eosinophils and macrophages in BAL fluid and the increased
airway smooth muscle mass were reversed within 6 weeks.
Therapeutic but not preventive NAC reduced AHR together
with a reversal of increased airway smooth muscle mass and
cellular apoptosis. Thus, while there was no recovery of ozone-
induced lung inflammation and emphysema, there were
therapeutic effects of NAC on AHR. The overall preventive and
therapeutic effects of NAC are summarised in Table 1.
Abbreviations: APA : apoptosis protease activating factor-1 ;
Cchord chord compliance; FEV: forced expiratory volume; FRC:
functional residual capacity; FVC: forced vital capacity; FEV25
and FEV50: percentage of FEV in first 25 and 50 msec of fast
expiration of FVC; HO-1 : haemoxygenase-1; IC: inspiratory
capacity; IL-1β: interleukin-1β; MMP-9 : macrophage
metalloproteinase 9; NE: no effect; SOD2 : superoxide
dismutase 2 ; TGFβ : transforming growth factor β ; TLC: total
lung capacity.
Chronic ozone exposure caused lung inflammation as
measured by increased numbers of BAL macrophages,
neutrophils and eosinophils, and by inflammatory cells in lungs.
BAL inflammation disappeared 6 weeks after cessation of
exposure, while lung inflammation scores remained elevated at
6 weeks. BAL inflammatory cells may be the reflection of the
transient effect of the final exposure to ozone, while the
persistence of the peribronchial and perivascular inflammation
in the lung tissue may represent a more chronic process. On
the other hand, gene expression of the pro-inflammatory
cytokine, IL-1β, remained elevated, and were unaffected by
NAC. IL-13, KC and IFNγ mRNA expression are also increased
in the model, as previously shown [5]. Increased lung TGF-β
mRNA that may contribute to airway wall remodelling and small
airway fibrosis [12] was also observed.
The increase in mean linear intercept after chronic ozone
exposure indicates an increase in alveolar size and is in line
with the increase in the lung volumes IC, FRC and TLC, with
airflow obstruction as indicated by a reduction in the ratios of
FEV25/FVC and FEV50/FVC. In addition, there was loss of lung
elastic recoil as noted by increased lung compliance. The
increase in alveolar size is most likely the result of alveolar
damage and loss of alveoli as shown on the histological lung
sections in Figure 5. The lung function changes observed on
cessation of ozone exposure are concordant with previous
studies of cigarette smoke exposure. In a smoke-induced
emphysema model in A/J mice, inflammation and emphysema
persisted after smoke cessation [11], while in another,
inflammatory cells and cytokines were decreased in BAL fluid,
NAC in Ozone-Induced Inflammation and Emphysema
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Figure 4.  Bronchoalveolar lavage fluid and plasma mediators.  Individual and mean concentrations of malonaldehyde in
bronchoalveolar lavage fluid (Panel A). Plasma levels of 8-hydroxy-deguanosine is shown in Panel B.
Individual and mean expression of IL-1β (Panel C), caspase-3 (Panel D), MMP-9 (Panel E), TGF-β (Panel F), SOD2 (Panel G) and
HO-1(Panel H) in lung tissue measured by quantitative RT-PCR. *P<0.05, **P<0.01, *** P<0.001.
doi: 10.1371/journal.pone.0080782.g004
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Figure 5.  Evidence of emphysema.  Representative photomicrographs of lung alveolar spaces in haematoxylin-eosin-stained
sections of air-exposed mice (Panel A), PBS-pretreated ozone-exposed mice (Panel B), NAC-pretreated ozone-exposed mice
(Panel C), air-exposed mice (Panel D), ozone-exposed PBS-treated mice (Panel E) ozone-exposed NAC-treated mice (Panel F).
Scale bar = 40µm. Panel G. Individual and mean values of mean linear intercept, Lm, in the lung sections from the 6 experimental
groups. *P<0.05, **P<0.01, *** P<0.001.
doi: 10.1371/journal.pone.0080782.g005
NAC in Ozone-Induced Inflammation and Emphysema
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Figure 6.  Changes in airway wall.  Individual and mean
values of relative proportion of epithelium (Panel A), airway
smooth muscle (ASM) (Panel B) and collagen (Panel C) in the
bronchial wall measured by point-counting of Masson trichrome
stained sections. *P<0.05, **P<0.01, *** P<0.001.
doi: 10.1371/journal.pone.0080782.g006
but lung tissue inflammation and alveolar enlargement
remained unchanged after smoke cessation [13]. We found up-
regulation of lung MMP-9 mRNA which can recruit
inflammatory cells and degrade anti-trypsin, resulting in
unchecked protease activity and tissue damage including
airspace enlargement [14]. We have previously shown an
increase in the protein expression of another
metalloproteinase, MMP-12, in our model [5]. Both MMP-9 and
MMP-12 are likely to be involved in ozone-induced
emphysema. Apoptosis of structural cells has also been
proposed as a mechanism of emphysema [15]. Markers of
apoptosis, caspase-3 gene expression and APA-1 protein
expression in the lung tissue, were increased after chronic
ozone exposure. However, caspase-3, not APA-1, receded
spontaneously after 6 weeks of cessation of ozone exposure,
indicating that some upregulated genes can revert with time to
pre-exposure levels.
AHR is another feature of COPD, occurring in a large
proportion of COPD patients [16,17]. A single ozone exposure
induces neutrophilic inflammation and transient AHR [18,19]
and the current study shows that chronic ozone exposure can
also induce sustained AHR. Associated with this, the proportion
of airway smooth muscle increased in ozone-exposed mice but
this returned to baseline values by 6 weeks. Increased airway
smooth muscle mass, increased airway smooth muscle
contractility and activation of p38MAPK-HSP27 pathway are
among the potential mechanisms for ozone-induced AHR [20].
Our study also demonstrated that preventive NAC did not
prevent ozone-induced AHR, but it reversed AHR during ozone
cessation period, which was associated with spontaneous
recovery of airway smooth muscle mass to baseline. NAC has
been shown to partly reduce LPS-induced AHR in mice [21]
and AHR induced by mycotoxin in an allergic asthma model
[22]. Thus, there is a reversible AHR component only with
therapeutic NAC, while the airway smooth muscle changes
reverted spontaneously.
Chronic ozone exposure resulted in an increase in BAL MDA
levels at six weeks after cessation of exposure, indicating a
delayed oxidative stress signal in the lungs. The expression of
the antioxidant superoxide dismutase 2 (SOD2) was enhanced
in response to ozone exposure. Both preventive and
therapeutic NAC had no effect on MDA levels in BAL of ozone-
exposed mice; however, preventive treatment with NAC led to
a reduction in plasma levels of the oxidative marker, 8-hydroxy-
deoxyguanosine. Ozone exposure itself could induce some
protective mechanism such as the promotion of CX3CR1-
dependent maturation of resident lung macrophages to limit
oxidative stress and inflammation [23]. NAC also did not
alterthe gene expression levels of SOD2 and HO-1. Overall,
the evidence we have would indicate that NAC was not having
an antioxidant effect. However, the possibility still remains that
the antioxidant effect was occurring intracellularly and was not
reflected in the levels of MDA or 8-hydroxy-deoxy-guanosine.
However, when given preventively, there was some evidence
of a systemic antioxidant effect.
Both preventive and therapeutic NAC administration did not
affect or reverse the development of ozone-induced
emphysema and this was associated with the failure to inhibit
NAC in Ozone-Induced Inflammation and Emphysema
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Figure 7.  Apoptotic cells.  Immunohistochemical analysis of the expression of apoptosis protease activating factor-1 (APA-1) in
airway epithelium and parenchyma of air-exposed mice (Panel A, G ), PBS-pretreated ozone-exposed mice (Panel B,H ), NAC-
pretreated ozone-exposed mice (Panel C, I ), air-exposed mice (Panel D, J), ozone-exposed PBS-treated mice (Panel E, K) ozone-
exposed NAC-treated mice (Panel F, L). Scale bar: 10µm for airway epithelial pictures and 20μm for lung parenchymal pictures.
Panel M. Individual and mean immunostaining scores of staining for APA in airway epithelial cells from the 6 experimental groups.
Panel N. Individual and mean score values of APA-1 positive cells counted in the lung parenchyma. *P<0.05, **P<0.01, *** P<0.001.
doi: 10.1371/journal.pone.0080782.g007
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caspase-3 or MMP-9 expression. However, therapeutic NAC
led to the inhibition of APA-1 expression and of APA-1 positive
cells. Previous studies have reported varying effects of NAC in
emphysema models. Thus, emphysema severity in cigarette
smoke-exposed mice was not improved by treatment with NAC
[11], while other studies in mouse or rat models of emphysema
including those induced by cigarette smoke exposure showed
prevention or amelioration of emphysema by preventive NAC
[24–26]. It is likely that our model represents an advanced state
of emphysema.
There is some discordance in terms of the differential effects
of preventive or therapeutic administration of NAC (Table 1).
For example, preventive NAC reduced BAL macrophage
numbers while therapeutic NAC reversed AHR and the
increase in airway smooth muscle mass, and the apoptotic
Table 1. Preventive and therapeutic effects of N-
acetylcysteine on chronic ozone effects.
Parameter Preventive NAC Therapeutic NAC
IC, FRC, TLC, Cchord NE NE
FEV25/FVC, FEV50/FVC NE ↓
Airway hyperresponsiveness NE Reverses AHR
Bronchoalveolar lavage cells ↓macrophage↑lymphocyte NE
Lung inflammation score NE NE
Mean linear intercept NE NE
Airway smooth muscle mass ↓ ↓
Epithelium NE ↑
Collagen NE NE
APA-1 cells NE ↓
IL-1β, Caspase 3, MMP-9, TGFβ
mRNA expression NE NE
SOD2 mRNA expression NE NE
HO-1 mRNA expression NE NE
BAL malondialdehyde levels NE NE
Plasma 8-hydroxy-deoxyguanosine ↓ NE
doi: 10.1371/journal.pone.0080782.t001
scores. There is no rational explanation for these differential
effects. One possibility is that the processes underlying the
effects are more readily reversed than preventable. The
bronchial hyperresponsiveness is likely to be related to the
changes in airway smooth muscle. The lack of effect of
preventive NAC could represent a poor effect of NAC in
preventing oxidative stress induced by ozone, while therapeutic
NAC could be more effective at later stages of oxidative stress
likely to be caused by endogenous processes such as the
activation of inflammation.
In COPD, smoking cessation is the only effective intervention
that could slow the accelerated decline in pulmonary function
[27] and improve AHR [28]. However, airway inflammation and
emphysema persist or even progress after 4 years of smoking
abstinence [29]. Some of the features of the chronic ozone
model are similar to these clinical observations. In this mouse
ozone model, we also demonstrate that there is no substantial
recovery of the damage inflicted by a chronic oxidant stress.
NAC administered therapeutically also did not affect
emphysema and the inflammatory process, but improved AHR
and ASM mass which may be the basis for potential clinical
benefits of NAC in COPD.
Supporting Information
Figure S1.  Protocol used in the six experimental groups.
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